Selected research
Industry Research
Non-Opioid Patch Industry Research Report 2026
Market perspective
The global Non-Opioid Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-Opioid Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-Opioid Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-Opioid Patch include Teva Pharmaceutical Industries Ltd, Johnson and Johnson, Viatris Inc., Sorrento Therapeutics Inc., Purdue Pharma L.P., NEXGEL Advanced Hydrogel Solutions, Hisamitsu Pharmaceutical Co.,Inc., Grunenthal and Endo International plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-Opioid Patch market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-Opioid Patch Market by Company
Teva Pharmaceutical Industries Ltd
Johnson and Johnson
Viatris Inc.
Sorrento Therapeutics Inc.
Purdue Pharma L.P.
NEXGEL Advanced Hydrogel Solutions
Hisamitsu Pharmaceutical Co.,Inc.
Grunenthal
Endo International plc.
Amneal Pharmaceuticals LLC
Non-Opioid Patch Segment by Type
Prescription Medicines
OTC Medicines
Non-Opioid Patch Segment by Application
Hospital Pharmacies
Drug Stores
Online Pharmacies
Non-Opioid Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Opioid Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Opioid Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Opioid Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-Opioid Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-Opioid Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Medicines
- OTC Medicines
Applications
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
Companies covered
- Teva Pharmaceutical Industries Ltd
- Johnson and Johnson
- Viatris Inc.
- Sorrento Therapeutics Inc.
- Purdue Pharma L.P.
- NEXGEL Advanced Hydrogel Solutions
- Hisamitsu Pharmaceutical Co.,Inc.
- Grunenthal
- Endo International plc.
- Amneal Pharmaceuticals LLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-Opioid Patch Market Size (2021-2032)
- 2.2.2 Global Non-Opioid Patch Sales (2021-2032)
- 2.2.3 Global Non-Opioid Patch Market Average Price (2021-2032)
- 2.3 Non-Opioid Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prescription Medicines
- 2.3.3 OTC Medicines
- 2.4 Non-Opioid Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Drug Stores
- 2.4.4 Online Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-Opioid Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-Opioid Patch Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Non-Opioid Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-Opioid Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-Opioid Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-Opioid Patch, Product Type & Application
- 3.8 Global Manufacturers of Non-Opioid Patch, Established Date
- 3.9 Global Non-Opioid Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries Ltd
- 4.1.1 Teva Pharmaceutical Industries Ltd Company Information
- 4.1.2 Teva Pharmaceutical Industries Ltd Business Overview
- 4.1.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.2 Johnson and Johnson
- 4.2.1 Johnson and Johnson Company Information
- 4.2.2 Johnson and Johnson Business Overview
- 4.2.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
- 4.2.5 Johnson and Johnson Recent Developments
- 4.3 Viatris Inc.
- 4.3.1 Viatris Inc. Company Information
- 4.3.2 Viatris Inc. Business Overview
- 4.3.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Viatris Inc. Non-Opioid Patch Product Portfolio
- 4.3.5 Viatris Inc. Recent Developments
- 4.4 Sorrento Therapeutics Inc.
- 4.4.1 Sorrento Therapeutics Inc. Company Information
- 4.4.2 Sorrento Therapeutics Inc. Business Overview
- 4.4.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
- 4.4.5 Sorrento Therapeutics Inc. Recent Developments
- 4.5 Purdue Pharma L.P.
- 4.5.1 Purdue Pharma L.P. Company Information
- 4.5.2 Purdue Pharma L.P. Business Overview
- 4.5.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
- 4.5.5 Purdue Pharma L.P. Recent Developments
- 4.6 NEXGEL Advanced Hydrogel Solutions
- 4.6.1 NEXGEL Advanced Hydrogel Solutions Company Information
- 4.6.2 NEXGEL Advanced Hydrogel Solutions Business Overview
- 4.6.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
- 4.6.5 NEXGEL Advanced Hydrogel Solutions Recent Developments
- 4.7 Hisamitsu Pharmaceutical Co.,Inc.
- 4.7.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
- 4.7.2 Hisamitsu Pharmaceutical Co.,Inc. Business Overview
- 4.7.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
- 4.7.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments
- 4.8 Grunenthal
- 4.8.1 Grunenthal Company Information
- 4.8.2 Grunenthal Business Overview
- 4.8.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Grunenthal Non-Opioid Patch Product Portfolio
- 4.8.5 Grunenthal Recent Developments
- 4.9 Endo International plc.
- 4.9.1 Endo International plc. Company Information
- 4.9.2 Endo International plc. Business Overview
- 4.9.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Endo International plc. Non-Opioid Patch Product Portfolio
- 4.9.5 Endo International plc. Recent Developments
- 4.10 Amneal Pharmaceuticals LLC
- 4.10.1 Amneal Pharmaceuticals LLC Company Information
- 4.10.2 Amneal Pharmaceuticals LLC Business Overview
- 4.10.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
- 4.10.5 Amneal Pharmaceuticals LLC Recent Developments
5 Global Non-Opioid Patch Market Scenario by Region
- 5.1 Global Non-Opioid Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-Opioid Patch Sales by Region: 2021-2032
- 5.2.1 Global Non-Opioid Patch Sales by Region: 2021-2026
- 5.2.2 Global Non-Opioid Patch Sales by Region: 2027-2032
- 5.3 Global Non-Opioid Patch Revenue by Region: 2021-2032
- 5.3.1 Global Non-Opioid Patch Revenue by Region: 2021-2026
- 5.3.2 Global Non-Opioid Patch Revenue by Region: 2027-2032
- 5.4 North America Non-Opioid Patch Market Facts & Figures by Country
- 5.4.1 North America Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-Opioid Patch Sales by Country (2021-2032)
- 5.4.3 North America Non-Opioid Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Non-Opioid Patch Market Facts & Figures by Country
- 5.5.1 Europe Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-Opioid Patch Sales by Country (2021-2032)
- 5.5.3 Europe Non-Opioid Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Non-Opioid Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-Opioid Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-Opioid Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-Opioid Patch Market Facts & Figures by Country
- 5.7.1 South America Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-Opioid Patch Sales by Country (2021-2032)
- 5.7.3 South America Non-Opioid Patch Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Non-Opioid Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-Opioid Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-Opioid Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-Opioid Patch Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Non-Opioid Patch Sales by Type (2021-2032)
- 6.1.1 Global Non-Opioid Patch Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Non-Opioid Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Non-Opioid Patch Revenue by Type (2021-2032)
- 6.2.1 Global Non-Opioid Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-Opioid Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-Opioid Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-Opioid Patch Sales by Application (2021-2032)
- 7.1.1 Global Non-Opioid Patch Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Non-Opioid Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Non-Opioid Patch Revenue by Application (2021-2032)
- 7.2.1 Global Non-Opioid Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-Opioid Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-Opioid Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-Opioid Patch Value Chain Analysis
- 8.1.1 Non-Opioid Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-Opioid Patch Production Mode & Process
- 8.2 Non-Opioid Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-Opioid Patch Distributors
- 8.2.3 Non-Opioid Patch Customers
9 Global Non-Opioid Patch Analyzing Market Dynamics
- 9.1 Non-Opioid Patch Industry Trends
- 9.2 Non-Opioid Patch Industry Drivers
- 9.3 Non-Opioid Patch Industry Opportunities and Challenges
- 9.4 Non-Opioid Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst